TP53 and neoplasm: Gene panel testing identified EGFR (p.T790M and p.L858R) mutations, TP53 mutation, tumor mutational burden (TMB 1.25Muts/Mb), PD-L1(TPS 5%, CPS 7), microsatellite stable (MSS).